MX2022014655A - Proceso para preparar (5s)-5-({2-[4-(butoxicarbonil)fenil]etil}[2- (2-{[3-cloro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil] amino)-5,6,7,8-tetrahidroquinolin-2-carboxilato de butilo. - Google Patents

Proceso para preparar (5s)-5-({2-[4-(butoxicarbonil)fenil]etil}[2- (2-{[3-cloro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil] amino)-5,6,7,8-tetrahidroquinolin-2-carboxilato de butilo.

Info

Publication number
MX2022014655A
MX2022014655A MX2022014655A MX2022014655A MX2022014655A MX 2022014655 A MX2022014655 A MX 2022014655A MX 2022014655 A MX2022014655 A MX 2022014655A MX 2022014655 A MX2022014655 A MX 2022014655A MX 2022014655 A MX2022014655 A MX 2022014655A
Authority
MX
Mexico
Prior art keywords
phenyl
ethyl
biphenyl
tetrahydroquinoline
butoxycarbonyl
Prior art date
Application number
MX2022014655A
Other languages
English (en)
Inventor
Peter Fey
Julian Egger
Marc Nowakowski
Nadine Bremeyer
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of MX2022014655A publication Critical patent/MX2022014655A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La presente invención se refiere a un proceso novedoso y mejorado para preparar (5S)-5-({2-[4-(butoxicarbonil)fenil]etil}[2-(2-{[3-c loro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil]amino)-5 ,6,7,8-tetrahidroquinolin-2-carboxilato de butilo de la fórmula (XII) (ver Fórmula) (XII) a novedosos precursores para su preparación y al uso para la preparación de ácido (5S)-5-{[2-(4-carboxifenil)etil][2-(2-{[3-cloro-4'-(trifluorometi l)[bifenil]-4-il]metoxi}fenil)etil]amino}-5,6,7,8-tetrahidroquino lin-2-carboxílico.
MX2022014655A 2020-05-20 2021-05-14 Proceso para preparar (5s)-5-({2-[4-(butoxicarbonil)fenil]etil}[2- (2-{[3-cloro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil] amino)-5,6,7,8-tetrahidroquinolin-2-carboxilato de butilo. MX2022014655A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20175721 2020-05-20
PCT/EP2021/062837 WO2021233783A1 (de) 2020-05-20 2021-05-14 Verfahren zur herstellung von butyl-(5s)-5-({2-[4-(butoxycarbonyl)phenyl]ethyl}[2-(2-{[3-chlor-4'-(trifluormethyl)[biphenyl]-4-yl]methoxy}phenyl)ethyl]amino)-5,6,7,8-tetrahydrochinolin-2-carboxylat

Publications (1)

Publication Number Publication Date
MX2022014655A true MX2022014655A (es) 2022-12-15

Family

ID=70802629

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022014655A MX2022014655A (es) 2020-05-20 2021-05-14 Proceso para preparar (5s)-5-({2-[4-(butoxicarbonil)fenil]etil}[2- (2-{[3-cloro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil] amino)-5,6,7,8-tetrahidroquinolin-2-carboxilato de butilo.

Country Status (14)

Country Link
US (1) US20230183181A1 (es)
EP (1) EP4153569A1 (es)
JP (1) JP2023526402A (es)
KR (1) KR20230012494A (es)
CN (1) CN115803318A (es)
AR (1) AR122140A1 (es)
AU (1) AU2021276066A1 (es)
BR (1) BR112022020799A2 (es)
CA (1) CA3183771A1 (es)
CL (1) CL2022003220A1 (es)
IL (1) IL298316A (es)
MX (1) MX2022014655A (es)
TW (1) TW202202140A (es)
WO (1) WO2021233783A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023126436A1 (en) 2021-12-29 2023-07-06 Bayer Aktiengesellschaft Process for preparing (5s)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4- yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound
WO2023126437A1 (en) 2021-12-29 2023-07-06 Bayer Aktiengesellschaft Treatment of cardiopulmonary disorders
AR128145A1 (es) 2021-12-29 2024-03-27 Bayer Ag Formulación farmacéutica de polvo seco para inhalación y proceso de preparación

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX365311B (es) * 2011-08-12 2019-05-29 Nissan Chemical Ind Ltd Compuestos heterocíclicos tricíclicos inhibidores de jak.
PT2875003T (pt) 2012-07-20 2017-02-16 Bayer Pharma AG Novos ácidos 5-amino-tetra-hidroquinolina-2-carboxílicos e sua utilização

Also Published As

Publication number Publication date
CA3183771A1 (en) 2021-11-25
AU2021276066A1 (en) 2022-12-08
CL2022003220A1 (es) 2023-03-10
WO2021233783A1 (de) 2021-11-25
TW202202140A (zh) 2022-01-16
CN115803318A (zh) 2023-03-14
AR122140A1 (es) 2022-08-17
JP2023526402A (ja) 2023-06-21
KR20230012494A (ko) 2023-01-26
US20230183181A1 (en) 2023-06-15
EP4153569A1 (de) 2023-03-29
IL298316A (en) 2023-01-01
BR112022020799A2 (pt) 2022-11-29

Similar Documents

Publication Publication Date Title
MX2022014655A (es) Proceso para preparar (5s)-5-({2-[4-(butoxicarbonil)fenil]etil}[2- (2-{[3-cloro-4'-(trifluorometil)[bifenil]-4-il]metoxi}fenil)etil] amino)-5,6,7,8-tetrahidroquinolin-2-carboxilato de butilo.
RU2498983C2 (ru) Соединения фениламинопиримидина и их применения
RU2386626C2 (ru) 1a, 5a-ТЕТРАГИДРО-S-ТИАЦИКЛОПРОПА[a]ПЕНТАЛЕНЫ:ТРИЦИКЛИЧЕСКИЕ ПРОИЗВОДНЫЕ ТИОФЕНА В КАЧЕСТВЕ АГОНИСТОВ РЕЦЕПТОРОВ S1P1/EDG1
PE20120136A1 (es) Compuestos derivados de n-acilsulfonamidas como inhibidores de bcl-2
AR048306A1 (es) Derivados de acidos carboxilicos aromaticos con capacidad moduladora de los niveles de insulina, composiciones farmaceuticas que los contienen y su uso en el tratamiento de trastornos metabolicos que responden a la regulacion de gpr40
RU2357959C2 (ru) Получение и применение арилалкильных производных кислот для лечения ожирения
JP2005522438A5 (es)
NZ603198A (en) Novel hydroxamic acid derivative
RU2010140668A (ru) Ингибиторы активности протеинтирозинкиназы
NZ604035A (en) Glycine transporter-1 inhibitors, methods of making them, and uses thereof
HRP20110009T1 (hr) Spoj kojim se aktivira ppar i farmaceutski pripravak koji ga sadrži
AR063946A1 (es) Determinadas pirimidinas sustituidas, el uso de las mismas para el tratamiento de enfermedades mediadas por la inhibicion de la actividad de btk y composiciones farmaceuticas que las comprenden.
EA001436B1 (ru) Антагонисты рецептора il-8
RU2008108984A (ru) Терапевтический агент от диабета
CA2564990A1 (en) Morpholine compounds
RU2011143740A (ru) Соединение пиримидина
JP2013505903A5 (es)
MX2010009401A (es) Forma cristalina de derivado de fenilamino pirimidina.
RU2009138351A (ru) Биарильные и бигетероарильные соединения, применяемые при лечении нарушений баланса железа
US7868046B2 (en) (2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing them
NZ602710A (en) Use of novel pan-cdk inhibitors for treating tumors
EA019037B1 (ru) 5-[5-[2-[3,5-бис(трифторметил)фенил-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил]-2-алкилпролинамиды в качестве антагонистов рецептора nk1
JP2007530478A5 (es)
RU2367654C2 (ru) Бензаннелированные соединения в качестве активаторов ppar
CA2416220A1 (en) Preparation of phosphatase inhibitors